11027. ちょっと怖かった素人の私(* ゚∀゚)

自画自賛?

素人だからで逃げる

10998. 素人最強

副作用度外視

副作用がない安全な薬と言わなくなっただけ進歩かな。

日本はアフリカと違って高齢者が多いからねー

切れ味は良くないね

Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19, A double-blind, randomized placebo-controlled trial.

Clinical outcome

During the study period four patients were referred to hospitals, with three of them being in the placebo arm. The first placebo-treated patient was hospitalized for 11 days with prolonged respiratory symptoms and needed oxygen even after  his discharge from hospital. The second was hospitalized for one day due to respiratory complaints. The third one  was referred to hospital due to headache and dizziness and was diagnosed with sinusitis after evaluation(brain CT and MRI). In addition, one asymptomatic patient became symptomatic, which occurred in the placebo group. In the ivermectin arm, one patient was referred to hospital due to shortness of breath at the day of recruitment. He continued the ivermectin and a day later was sent back to the hotel in good condition.

発症3日以内って基準したら人数が集められなくて、それでエントリーできる人を発症後の日数を変えて増やしている。

最初から「重症化」を指標に、発症者だけを集めたほうが「治療効果」を見ることになり、臨床的な意味は深かったのではなかろうか?